Batch queries can be done using pipe "|" as a separator between search terms.
LOVD - Variant listings for MSH6

About this overview [Show]

1 public entry
entries per page

Path. Hide Path. column Descending
Ascending

Exon Hide Exon column Descending
Ascending

DNA change   Descending
Ascending

RNA change Hide RNA change column Descending
Ascending

Protein Hide Protein column Descending
Ascending

MAPP/PP2 Prior P Hide MAPP/PP2 Prior P column Descending
Ascending

Prior P Hide Prior P column Descending
Ascending

IARC Classification Hide IARC Classification column Descending
Ascending

InSiGHT Classification Hide InSiGHT Classification column Descending
Ascending

Tumour Char LR Hide Tumour Char LR column Descending
Ascending

Segregation LR Hide Segregation LR column Descending
Ascending

Odds for causality Hide Odds for causality column Descending
Ascending

Posterior P Hide Posterior P column Descending
Ascending

Reference Hide Reference column Descending
Ascending

Variant remarks Hide Variant remarks column Descending
Ascending

Template Hide Template column Descending
Ascending

Technique Hide Technique column Descending
Ascending

DB-ID Hide DB-ID column Descending
Ascending

Disease Hide Disease column Descending
Ascending

Reference Hide Reference column Descending
Ascending

Remarks Hide Remarks column Descending
Ascending
+/+ 4 c.1346T>C r.(?) p.(Leu449Pro) 0.951 0.900 Class 5: Pathogenic Class 5: Pathogenic 1633.226 8686.024 1.42E+07 1.0000 Thompson et al., 2014, InSiGHT - DNA SEQ MSH6_00007 - - -
1


Save Click here to save this list in a tab-delimited text file.

Note: Direct classification on the basis of the prior probability alone is a misuse of the Bayesian integrated evaluation model, therefore the dynamic range of the prior probability (Prior P) has been truncated to a minimum of 0.10 and a maximum of 0.90 so that additional sources of information are required to reach posterior probabilities that alter clinical management of patients with variants.

Legend: [ MSH6 full legend ]
Sequence variations are described basically as recommended by the Ad-Hoc Committee for Mutation Nomenclature (AHCMN), with the recently suggested additions (den Dunnen JT and Antonarakis SE [2000], Hum.Mut. 15:7-12); for a summary see Nomenclature.
Path.: Variant pathogenicity, in the format Reported/Concluded; '+' indicating the variant is pathogenic, '+?' probably pathogenic, '-' no known pathogenicity, '-?' probably no pathogenicity, '?' effect unknown. Exon: Exon numbering. DNA change: Variation at DNA-level. If present, "Full Details" will show you the the full-length entry. RNA change: Variation at RNA-level, (?) unknown but probably identical to DNA. Protein: Variation at protein level. MAPP/PP2 Prior P: MAPP/PP2 Prior probability of pathogenicity Prior P: Prior probability of pathogenicity (used in Bayes Integrated Evaluation/Multifactorial Likelihood Analysis) IARC Classification: IARC Classification InSiGHT Classification: 5-tiered classification on the InSiGHT database Tumour Char LR: Tumour characteristics likelihood ratio Segregation LR: Segregation likelihood ratio Odds for causality: Product of LRs Posterior P: Posterior probability of pathogenicity Reference: Reference describing the variation, "Submitted:" indicating that the mutation was submitted directly to this database. Variant remarks: Variant remarks Template: Variant detected in DNA, RNA and/or Protein. Technique: Technique used to detect the variation. MSH6 DB-ID: Database IDentifier; When available, links to OMIM ID's are provided. Disease: Disease phenotype, as reported in paper/by submitter, unless modified by the curator. Reference: Reference describing the patient, "Submitted:" indicating that the mutation was submitted directly to this database.